Litigation Details for Pharmacyclics LLC v. Acerta Pharma B v. (D. Del. 2017)
✉ Email this page to a colleague
Pharmacyclics LLC v. Acerta Pharma B v. (D. Del. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-11-03 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | Plaintiff | Referred To | |
Patents | 9,556,182 | ||
Link to Docket | External link to docket |
Biologic Drugs cited in Pharmacyclics LLC v. Acerta Pharma B v.
The biologic drugs covered by the patent cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Pharmacyclics LLC v. Acerta Pharma B v. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-08-07 | 173 | Order - -Memorandum and Order | ;the ' 591 patent"), and 9,556,182 ("the ' 182 patent") (collectively, "the…for multiple terms in U.S. Patent Nos. 9,079,908, 9,139,591, and 9,556,182. Signed by Judge Richard G.…of multiple terms in U.S. Patent Nos. 9,079,908 ("the ' 908 patent"), 9,139,591 ("the… infringement of the asserted patents. (D.I. 1). The asserted patents relate to small molecule compounds…asserted patents. B. LEGAL STANDARD "It is a bedrock principle of patent law that the | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |